Key facts
- hc1 Insights’s last known valuation is $32.4M (Oct 2015).
- It has raised $43.1M across 1 recorded rounds; the latest was Early Stage VC ($6.5M) in Aug 2024.
- Notable investors include Elevate Ventures, Claritas Capital, Beyond Capital, A1 Health Ventures, Abundant Venture Partners — 7 tracked in total.
- hc1 Insights has filed 1 Form D with the SEC, most recently Sep 2024 ($6.5M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for hc1 Insights
Funding rounds
1 roundsAbout hc1 Insights
Developer of a cloud-based healthcare relationship management platform designed to personalize the experience of doctors and the patients whom they serve. The company's platform increases internal efficiency and communication while decreasing manual reporting, and tracks test utilization metrics and benchmarks to cut back on unnecessary or unreimbursed tests, enabling healthcare providers to deliver improved experiences to their clients and patients.
- Sector
- Healthcare
- HQ
- Indianapolis, IN, United States
- Employees
- 225
- Website
- hc1.com/
- Ownership
- Privately Held (backing)
hc1 Insights doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in hc1 Insights shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on hc1 Insights in its N-PORT filings yet. We sweep new filings monthly.